ARTICLE | Company News
Quest Diagnostics sales and marketing update
June 22, 2009 7:00 AM UTC
Quest launched its HIV-1 Coreceptor Tropism Test to help determine whether an HIV patient with a history of drug resistance will respond to treatment with CC chemokine receptor 4 (CCR4) and CCR5 inh...